The spleen size in patients undergoing hemodialysis
- PMID: 33079128
- PMCID: PMC8061966
- DOI: 10.1590/2175-8239-JBN-2020-0116
The spleen size in patients undergoing hemodialysis
Erratum in
-
Erratum.J Bras Nefrol. 2021 Jan-Mar;43(1):142. doi: 10.1590/2175-8239-jbn-2020-0116er. J Bras Nefrol. 2021. PMID: 33503109 Free PMC article.
Abstract
Introduction: Inflammation promotes the progression of chronic renal failure, and the start of dialysis worsens inflammation. The enlargement of the spleen is associated with inflammation, and patients on hemodialysis may show a large spleen. The aim of the present study was to compare the spleen size of patients undergoing hemodialysis versus controls to update this thread.
Methods: Controls and patients were eligible to participate in the study provided they were negative for serological markers of hepatitis B and C viruses and HIV, if they had no lymphoproliferative disorder, and if they were at least 18 years of age. Age, sex, and the duration of dialysis were recorded. Laboratory variables (hemoglobin, hematological cell count, serum creatinine) and the underlying cause of end-stage renal disease were analyzed. The spleen sizes of the patients were divided into tertiles.
Results: The 75 controls and 168 patients selected were sex-matched. The patients were older, had larger spleens and lower platelet counts than controls. The relationship between spleen size and age in the controls and patients was quite similar. The patients in the first tertile of spleen size compared with those in the third were older and had a higher platelet counts. The underlying disease and dialysis vintage had no effect on spleen size.
Discussion: The patients had larger spleens and a greater range of spleen sizes than the controls. In patients, the association between larger and smaller spleen with lower and higher platelet counts, respectively, sparked the speculation of occurrence of hypersplenism and hyposplenism.
Introdução:: A inflamação promove a progressão da insuficiência renal crônica, e o início da diálise agrava a inflamação. O aumento do baço está associado à inflamação e os pacientes em hemodiálise podem apresentar um baço grande. O objetivo do presente estudo foi comparar o tamanho do baço de pacientes em hemodiálise versus aquele de controles, para atualizar este tópico.
Métodos:: Controles e pacientes foram elegíveis para participar do estudo desde que fossem negativos para marcadores sorológicos dos vírus da hepatite B, C e HIV, se não apresentassem distúrbio linfoproliferativo e tivessem pelo menos 18 anos de idade. Registramos idade, sexo e duração da diálise. Avaliamos as variáveis laboratoriais (hemoglobina, contagem de células hematológicas, creatinina sérica) e a causa básica da doença renal terminal. O tamanho dos baços dos pacientes foram divididos em tercis.
Resultados:: Os 75 controles e 168 pacientes selecionados foram pareados por sexo. Os pacientes eram mais velhos, tinham baços maiores e menor contagem de plaquetas do que os controles. A relação entre o tamanho do baço e a idade dos controles e pacientes foi bastante semelhante. Os pacientes do primeiro tercil de tamanho do baço, em comparação com os do terceiro, eram mais velhos e apresentavam contagens de plaquetas mais altas. A doença subjacente e o período de diálise não tiveram efeito no tamanho do baço.
Discussão:: Os pacientes tinham baços maiores e uma maior variedade de tamanhos de baço do que os controles. Entre os pacientes, a associação entre baço maior e menor com contagens de plaquetas mais baixas e mais altas, respectivamente, gerou a especulação da ocorrência de hiperesplenismo e hiposplenismo.
Conflict of interest statement
The authors declare that they have no conflict of interest related to the publication of this manuscript.
Figures
Similar articles
-
New insights into the thrombopoietic status of patients on dialysis through the evaluation of megakaryocytopoiesis in bone marrow and of endogenous thrombopoietin levels.Blood. 2001 Feb 15;97(4):915-21. doi: 10.1182/blood.v97.4.915. Blood. 2001. PMID: 11159517
-
Use of electron-beam sterilized hemodialysis membranes and risk of thrombocytopenia.JAMA. 2011 Oct 19;306(15):1679-87. doi: 10.1001/jama.2011.1499. JAMA. 2011. PMID: 22009100
-
Increased serum renalase in hemodialysis patients: is it related to left ventricular hypertrophy?Ren Fail. 2016 Sep;38(8):1180-6. doi: 10.1080/0886022X.2016.1208516. Epub 2016 Jul 14. Ren Fail. 2016. PMID: 27416751
-
Timing of dialysis initiation, duration and frequency of hemodialysis sessions, and membrane flux: a systematic review for a KDOQI clinical practice guideline.Am J Kidney Dis. 2015 Nov;66(5):823-36. doi: 10.1053/j.ajkd.2014.11.031. Am J Kidney Dis. 2015. PMID: 26498415 Review.
-
Hepatitis B and C and renal failure.Infect Dis Clin North Am. 2001 Sep;15(3):877-99. doi: 10.1016/s0891-5520(05)70177-x. Infect Dis Clin North Am. 2001. PMID: 11570146 Review.
Cited by
-
Deciphering the Molecular Mechanism of Yifei-Sanjie Pill in Cancer-Related Fatigue.J Oncol. 2023 Feb 13;2023:5486017. doi: 10.1155/2023/5486017. eCollection 2023. J Oncol. 2023. PMID: 36814560 Free PMC article.
-
Transcranial sonography depicts a larger substantia nigra echogenic area in renal transplant patients on calcineurin inhibitors than on rapamycin.BMC Nephrol. 2022 Mar 17;23(1):108. doi: 10.1186/s12882-022-02741-7. BMC Nephrol. 2022. PMID: 35300603 Free PMC article.
References
-
- Silverstein DM. Inflammation in chronic kidney disease: role in the progression of renal and cardiovascular disease. Pediatr Nephrol. 2008 Aug;24(8):1445–1452. - PubMed
-
- Jofré R, Rodriguez-Benites P, López-Gómez JM, Pérez-Garcia R. Inflammatory syndrome in patients on hemodialysis. J Am Soc Nephrol. 2006 Dec;17(12) Suppl 3:S274–SS80. - PubMed
-
- Girndt M, Kaul H, Leitnaker CK, Sester M, Sester U, Köhler H. Selective sequestration of cytokine-producing monocytes during hemodialysis treatment. Am J Kidney Dis. 2001 May;37(5):954–963. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical